Avantor Business Summary

Avantor, Inc. (AVTR) operates as a leading global provider of mission-critical products and services for the biopharma, healthcare, education, government, and advanced technologies sectors. The company generates revenue through a high-volume, recurring model centered on the sale of materials, consumables, and specialized services. As of early 2026, Avantor has reorganized into two primary segments: Laboratory Solutions, which leverages the globally recognized VWR brand as a product-agnostic distribution channel, and Bioscience Production, a channel-agnostic unit focused on high-purity chemicals, single-use assemblies, and proprietary excipients. Despite a transition year in 2026 marked by its "Revival" strategic program to modernize digital and supply chain infrastructure, Avantor maintains a massive global footprint serving over 300,000 locations. It competes directly with diversified life sciences giants such as Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies, positioning itself as a specialized partner that integrates high-margin proprietary manufacturing with a comprehensive third-party distribution engine. Leadership is currently spearheaded by President and CEO Emmanuel Ligner, who took the helm in August 2025 following a distinguished tenure as CEO of Cytiva (formerly GE Life Sciences) and Cerba HealthCare. He is supported by Executive Vice President and CFO R. Brent Jones, formerly of LifeScan and Pall Corporation, and newly appointed COO Mary Blenn, who brings extensive operational expertise from the Danaher/GE ecosystem. The company’s strategic direction is overseen by Chairman Gregory L. Summe, the Managing Partner of Glen Capital Partners and former CEO of PerkinElmer, who assumed the role in January 2026. The board has been further strengthened by the recent appointments of Simon Dingemans, a former GSK CFO and Carlyle Group advisor, and Greg Lucier, former CEO of Life Technologies. While originally transformed into its modern iteration by New Mountain Capital in 2010, the company now operates with a focus on deleveraging and operational efficiency under the influence of institutional stakeholders and activist interest from firms like Engine Capital.